publications Archives - Bolt Biotherapeutics

Publication

Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor [...]

By Andrea Tu|2020-12-07T14:20:19-08:00July 7, 2020|publications|Comments Off

Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate [...]

By Andrea Tu|2020-12-09T05:47:43-08:00June 8, 2020|publications|Comments Off

Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate [...]

By Andrea Tu|2020-11-10T20:38:09-08:00November 10, 2019|publications|Comments Off

Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives [...]

By Andrea Tu|2020-11-10T20:40:58-08:00November 10, 2019|publications|Comments Off

Systemically administered HER2-targeted ISACs provoke a rapid, local response that [...]

By Andrea Tu|2020-11-10T20:55:21-08:00November 10, 2019|publications|Comments Off

HER2-targeting TLR 7/8 immune-stimulating antibody conjugates elicit robust myeloid activation [...]

By Andrea Tu|2020-10-12T13:13:27-07:00November 6, 2019|publications|Comments Off

TLR7/8 immune stimulating antibody conjugates elicit robust myeloid activation and [...]

By Andrea Tu|2020-10-12T13:14:00-07:00April 9, 2019|publications|Comments Off

Systemic Immunity is Required for Effective Cancer Immunotherapy Spitzer MH, [...]

By Andrea Tu|2020-10-12T15:57:27-07:00February 5, 2019|publications|Comments Off

Allogenic IgG Combined with Dendritic Cell Stimuli Induce Antitumor T-cell [...]

By Andrea Tu|2020-10-12T13:14:56-07:00February 4, 2019|publications|Comments Off